The Research Institute for Gender Therapeutics (RIGT) is a nonprofit pharmaceutical company and a registered 501c3 public charity that was founded to address the significant unmet medical and social needs of gender diverse individuals. The clinical treatment of gender diverse individuals in often stigmatized, under-researched, and there are no FDA-approved treatments for gender dysphoria. RIGT was established to address these issues and has recruited a team of world renowned experts in gender care to guide our organization and help support a world where the treatment of gender diverse individuals is broadly accepted as standard medical practice.
Mission Statement
To bring clinical treatment of gender diverse individuals into standard medical practice by researching, developing, and seeking formal regulatory approval of therapeutic options for gender dysphoria.